During recent decades, the life expectancy of people with cystic fibrosis (pwCF) has increased dramatically, and treatment with cystic fibrosis transmembrane regulator (CFTR) modulators will likely contribute to further improvements. This evidence concerns the gene CFTR and cystic fibrosis.